Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free OCEAW Stock Alerts

Ocean Biomedical (OCEAW) Competitors

Compare

OCEAW vs. SXTPW, BFRIW, CALA, CINGW, and CLVR

Should you buy Ocean Biomedical stock or one of its competitors? Ocean Biomedical's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Calithera Biosciences (CALA), Cingulate (CINGW), and Clever Leaves (CLVR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Ocean Biomedical compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Ocean Biomedical (NASDAQ:OCEAW) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Ocean Biomedical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
Ocean BiomedicalN/AN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals had 2 more articles in the media than Ocean Biomedical. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Ocean Biomedical. 60 Degrees Pharmaceuticals' average media sentiment score of 1.93 beat Ocean Biomedical's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
60 Degrees Pharmaceuticals Very Positive
Ocean Biomedical Neutral

Summary

60 Degrees Pharmaceuticals beats Ocean Biomedical on 3 of the 3 factors compared between the two stocks.

How does Ocean Biomedical compare to Biofrontera?

Ocean Biomedical (NASDAQ:OCEAW) and Biofrontera (NASDAQ:BFRIW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation.

In the previous week, Biofrontera had 3 more articles in the media than Ocean Biomedical. MarketBeat recorded 3 mentions for Biofrontera and 0 mentions for Ocean Biomedical. Biofrontera's average media sentiment score of 0.96 beat Ocean Biomedical's score of 0.00 indicating that Biofrontera is being referred to more favorably in the news media.

Company Overall Sentiment
Ocean Biomedical Neutral
Biofrontera Positive

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Biofrontera N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

Summary

Biofrontera beats Ocean Biomedical on 3 of the 3 factors compared between the two stocks.

How does Ocean Biomedical compare to Calithera Biosciences?

Ocean Biomedical (NASDAQ:OCEAW) and Calithera Biosciences (NASDAQ:CALA) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, risk, institutional ownership and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
Calithera BiosciencesN/AN/A-$39.65MN/AN/A

In the previous week, Calithera Biosciences had 1 more articles in the media than Ocean Biomedical. MarketBeat recorded 1 mentions for Calithera Biosciences and 0 mentions for Ocean Biomedical. Ocean Biomedical's average media sentiment score of 0.00 equaled Calithera Biosciences'average media sentiment score.

Company Overall Sentiment
Ocean Biomedical Neutral
Calithera Biosciences Neutral

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Calithera Biosciences N/A N/A N/A

Summary

Calithera Biosciences beats Ocean Biomedical on 1 of the 1 factors compared between the two stocks.

How does Ocean Biomedical compare to Cingulate?

Ocean Biomedical (NASDAQ:OCEAW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Cingulate N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

In the previous week, Cingulate had 2 more articles in the media than Ocean Biomedical. MarketBeat recorded 2 mentions for Cingulate and 0 mentions for Ocean Biomedical. Cingulate's average media sentiment score of 1.44 beat Ocean Biomedical's score of 0.00 indicating that Cingulate is being referred to more favorably in the news media.

Company Overall Sentiment
Ocean Biomedical Neutral
Cingulate Positive

Summary

Cingulate beats Ocean Biomedical on 2 of the 2 factors compared between the two stocks.

How does Ocean Biomedical compare to Clever Leaves?

Ocean Biomedical (NASDAQ:OCEAW) and Clever Leaves (NASDAQ:CLVR) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

6.9% of Clever Leaves shares are held by institutional investors. 8.2% of Clever Leaves shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Clever Leaves had 1 more articles in the media than Ocean Biomedical. MarketBeat recorded 1 mentions for Clever Leaves and 0 mentions for Ocean Biomedical. Ocean Biomedical's average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score.

Company Overall Sentiment
Ocean Biomedical Neutral
Clever Leaves Neutral

Ocean Biomedical has higher earnings, but lower revenue than Clever Leaves.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
Clever Leaves$17.42M0.00-$17.90M-$12.36N/A

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Clever Leaves N/A N/A N/A

Summary

Clever Leaves beats Ocean Biomedical on 4 of the 4 factors compared between the two stocks.

Get Ocean Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OCEAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OCEAW vs. The Competition

Export
MetricOcean BiomedicalPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$11.83B$7.03B$13.06B
Dividend YieldN/A2.69%2.56%10.62%
P/E RatioN/A779.61270.8525.39
Price / SalesN/A745.10597.3988.49
Price / CashN/A15.0328.8738.47
Price / BookN/A10.4011.096.51
Net IncomeN/A$2.78B$3.45B$347.22M

Ocean Biomedical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OCEAW
Ocean Biomedical
N/AN/AN/AN/A$0.00N/AN/A2
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
-15.5%		N/AN/A$0.00$1.00MN/A2
BFRIW
Biofrontera
N/A$0.02
-21.3%		N/A-75.2%$0.00$43.20MN/A70
CALA
Calithera Biosciences
N/AN/AN/AN/A$0.00N/AN/A60
CINGW
Cingulate
N/A$0.01
+2.5%		N/A-84.4%$0.00N/AN/A20

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:OCEAW) was last updated on 8/17/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel